- Losers: Oragenics (OGEN) -45% after pricing $2.1M stock offering.
- Palatin Technologies (PTN) -37% announces results of PL9643 MELODY-1 pivotal phase 3 clinical trial in patients with dry eye disease.
- Integral Ad Science Holding Corp (IAS) -26% after Q4 earnings release.
- Novavax (NVAX) -19% reports fourth Quarter and full year 2023 financial results and operational highlights.
- SolarMax Technology (SMXT) -18%.
- 3D Systems Corp. (DDD) -17% after Q4 earnings release.
- Vertex Energy (VTNR) -17% reports Q4 results.
- Lemonade (LMND) -16% after Q4 earnings release.
- DoubleVerify Holdings (DV) -14%.
- Sarcos Technology and Robotics Corporation (STRC) -14%.
- Payoneer Global (PAYO) -13% after Q4 earnings release.
- Annovis Bio (ANVS) -12%.
- Amesite (AMST) -12%.
- Bumble (BMBL) -12% after Q4 earnings release.
- Recursion Pharmaceuticals (RXRX) -11% after Q4 earnings release.
- Luminar Technologies (LAZR) -10% after Q4 earnings release.
- Infobird Co Ltd (IFBD) -9%.
- Cellectis (CLLS) -7%.
- Virgin Galactic Holdings (SPCE) -7% after Q4 earnings release.
- Bit Origin Ltd (BTOG) -7%.
- Fusion Fuel Green Ltd (HTOO) -6%.
- reAlpha Tech Corp. (AIRE) -5%.
- Opko Health (OPK) -6% after Q4 earnings release.
More on pre-market losers & stocks.
- Annovis: Potentially Encouraging Anecdotes, Weighing Phase 3 Parkinson's Prospects
- Annovis And Alzheimer's Disease: The Best-Laid Plans
- Stocks To Watch: Eyes On Chipmakers, Tesla, Netflix And BrightSpring IPO
- Infobird to effect 1-for-8 reverse stock split to regain compliance with Nasdaq rules
- Annovis falls 16% on Phase 3 data delay for Parkinson's drug